Amp Capital Investors LTD Biogen Inc. Transaction History

Amp Capital Investors LTD

$0
Q4 2022

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $10.7 Million - $13.7 Million	-47,753 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $1.81 Million - $2.36 Million	-6,387 Reduced 11.8%	47,753 $13.5 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $3.36 Million - $5.37 Million	-12,955 Reduced 19.31%	54,140 $18.7 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $1.93 Million - $2.27 Million	-7,962 Reduced 10.61%	67,095 $18.7 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $4.89 Million - $7.37 Million	-20,714 Reduced 21.63%	75,057 $18.3 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $2.63 Million - $3.03 Million	-9,915 Reduced 9.38%	95,771 $27 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $6.24 Million - $8.27 Million	-24,141 Reduced 18.59%	105,686 $27.5 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $2.44 Million - $3.1 Million	-9,076 Reduced 6.53%	129,827 $41 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $4.02 Million - $5.56 Million	-18,283 Reduced 11.63%	138,903 $41.1 Million
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $5.01 Million - $5.62 Million	-23,042 Reduced 12.78%	157,186 $36.2 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $124,995 - $137,780	570 Added 0.32%	180,228 $43.2 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $8.68 Million - $13.6 Million	40,064 Added 28.7%	179,658 $41.8 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $422,763 - $535,474	-1,518 Reduced 1.08%	139,594 $41 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $1.86 Million - $2.44 Million	-6,349 Reduced 4.31%	141,112 $50.2 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $4.52 Million - $5.38 Million	17,540 Added 13.5%	147,461 $42.8 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $3.47 Million - $4.9 Million	13,328 Added 11.43%	129,921 $35.3 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $5.22 Million - $5.84 Million	16,952 Added 17.01%	116,593 $37.1 Million
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $681,226 - $798,838	-2,423 Reduced 2.37%	99,641 $31.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	102,064	102,064 $27.7 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.

Account